Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis-Reference-Cited by-同舟云学术

Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis

Published:2014-09 Issue:9 Volume:106 Page:
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Nagayama Aiko,Hayashida Tetsu,Jinno Hiromitsu,Takahashi Maiko,Seki Tomoko,Matsumoto Akiko,Murata Takeshi,Ashrafian Hutan,Athanasiou Thanos,Okabayashi Koji,Kitagawa Yuko

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/106/9/dju203/17313483/dju203.pdf

Reference37 articles.

1. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine;Ross;Oncologist,2009

2. Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials;Viani;BMC Cancer,2007

3. The efficacy of HER2-targeted agents in metastatic breast cancer: a meta-analysis;Harris;Ann Oncol,2011

4. Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: a systematic review and meta-analysis;Valachis;Breast,2011

5. New strategies in HER2-overexpressing breast cancer: many combinations of targeted drugs available;Abramson;Clin Cancer Res,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of HER2-low breast cancer: Insights from a six-year study on prevalence and clinicopathological characteristics;Annals of Diagnostic Pathology;2024-10

2. Unveiling Neoadjuvant Therapy: Insights and Outlooks for HER2-Positive Early Breast Cancer;Current Treatment Options in Oncology;2024-08-17

3. Associations of pre-diagnosis physical activity with treatment tolerance and treatment efficacy in breast cancer patients with neoadjuvant chemotherapy;Breast Cancer;2024-04-02

4. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17

5. Convenient determination of serum HER‐2 status in breast cancer patients using Raman spectroscopy;Journal of Biophotonics;2024-01-28